| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |